or Try an Advanced Search...

    Precision Medicine Stocks List

    Symbol Grade Name % Change
    RPTX F Repare Therapeutics Inc. 0.65
    CRSP F CRISPR Therapeutics AG -0.88
    ORIC F Oric Pharmaceuticals, Inc. -2.84
    EXAI F Exscientia Limited -0.85
    RLAY F Relay Therapeutics, Inc. -2.29
    BIOR F Biora Therapeutics, Inc. 19.44
    POAI F Predictive Oncology Inc. -3.06
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
    Related Stock Lists: Biology Biotechnology Medicine Cancer Disease Molecular Biology Systems Biology Biomarkers Biopharmaceutical Cancer Treatment Checkpoint Inhibitor Clinical Development Drug Discovery Emerging Technologies Evidence Based Medicine Immune System Oncology Proteins Solid Tumors Targeted Therapy

    Related ETFs - A few ETFs which own one or more of the above listed Precision Medicine stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.99
    GNOM D Global X Genomics & Biotechnology ETF 4.45
    SBIO D ALPS Medical Breakthroughs ETF 3.53
    ARKK F ARK Innovation ETF 2.98
    XHS D SPDR S&P Health Care Services ETF 2.61
    View all Precision Medicine ETFs...
    Compare ETFs
    Compare ARKG to GNOM Compare GNOM to SBIO Compare GNOM to XHS

        Precision Medicine Stocks Recent News

        Date Stock Title
        May 24 EXAI Exscientia plc (EXAI) Q1 2024 Earnings Call Transcript
        May 23 EXAI Exscientia (EXAI) Upgraded to Buy: Here's What You Should Know
        May 23 CRSP Crispr Therapeutics appoints Patel as CMO, Bruno as COO
        May 23 CRSP CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
        May 22 CRSP Is CRISPR Therapeutics a Millionaire Maker?
        May 22 EXAI Regeneron faces new biosimilar threats; An AI biotech lays off staff
        May 22 CRSP Bull Market Buys: 2 Growth Stocks to Own for the Long Run
        May 22 EXAI Q1 2024 Exscientia PLC Earnings Call
        May 22 EXAI Exscientia: Drug Discovery Platform Attracting Partners And Cash
        May 21 EXAI Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon
        May 21 EXAI Exscientia to lay off up to 25% of employees; shares down 10%
        May 21 EXAI Exscientia GAAP EPS of -$0.21, revenue of $6.7M
        May 21 EXAI Exscientia Business Update for First Quarter 2024
        May 20 EXAI Exscientia Q1 2024 Earnings Preview
        May 20 BIOR Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
        Related Industries: Biotechnology Diagnostics & Research Health Information Services Medical Instruments & Supplies
        Related Stock Lists: Biology Biotechnology Medicine Cancer Disease Molecular Biology Systems Biology Biomarkers Biopharmaceutical Cancer Treatment Checkpoint Inhibitor Clinical Development Drug Discovery Emerging Technologies Evidence Based Medicine Immune System Oncology Proteins Solid Tumors Targeted Therapy
        Precision Medicine

        Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a one‐drug‐fits‐all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

        More about Precision Medicine
        Browse All Tags